References
- Verstraete E, Biessels GJ, van den Heuvel MP, Visser F, Luijten PR, van den Berg LH. No evidence of microbleeds in ALS patients at 7 Tesla MRI. Amyotroph Lateral Scler. 2010; 11:555–7.
- Zhong Z, Deane R, Ali Z, Parisi M, Shapovalov Y, O'Banion MK, . ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci. 2008; 11:420–2.
- Zhong Z, Ilieva H, Hallagan L, Bell R, Singh I, Paquette N, . Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells. J Clin Invest. 2009; 119:3437–49.
- Nicaise C, Mitrecic D, Demetter P, de Decker R, Authelet M, Boom A, . Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat. Brain Res. 2009; 1301:152–62.
- Greenberg SM, Nandigam RN, Delgado P, Betensky SA, Rosand J, Viswanathan A, . Microbleeds versus macrobleeds: evidence for distinct entities. Stroke. 2009;40:2382–6.
- Henkel JS, Beers DR, Wen S, Bowser R, Appel SH. Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS. Neurology. 2009;72:1614–6.
- Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, . Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron. 2010; 68:409–27.
- Chen ZL, Stickland S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell. 1997;91:917–25.
- Mhatre M, Nguyen A, Kashani S, Pham T, Adesina A, Grammas P. Thrombin, a mediator of neurotoxicity and memory impairment. Neurobiol Aging. 2004;25:783–93.
- Garbuzova-Davis S, Saporta S, Haller E, Kolomey I, Bennett SP, Potter H, . Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modelling ALS. PLoS ONE. 2007;2:1205.